Onyx Pharmaceuticals Inc.

Public Company, Headquarters Location
2100 Powell St., Emeryville, CA 94608-1826, United States
(510)597-6500, (510)597-6600 fax, http://www.onyx-pharm.com

Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Research and development of pharmaceuticals to treat cancer on a genetic basis.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Onyx Pharmaceuticals Inc., News and Information

Alethia Biotherapeutics Strengthens its Board of Directors.
Marketwire Canada; 12/15/2009; 822 words; ...and AEA Investors Inc, where he was responsible...of Research for the Pharmaceutical Division of Bayer Corporation...Trillium Therapeutics Inc. and has previously...board of directors of Onyx Pharmaceuticals, Myriad Genetics and Catalyst Biosciences Inc. Dr. Berendt holds...

Onyx Pharmaceuticals Completes Acquisition of Proteolix, Inc.
Blood Weekly; 12/3/2009; 657 words; ...this strategic transaction, Onyx reaches an important milestone...chief executive officer of Onyx. "The lead asset, carfilzomib...Drugs, Hematology, Oncology, Onyx Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company...

CytRx Expands Management Team and Broadens Oncology Franchise.
Business Wire; 12/1/2009; 1321 words; ...registration or partnering with pharmaceutical or biotechnology companies...Operations at Cerimon Pharmaceuticals, Inc., where he was responsible...Development at TRF Pharma, Inc.; Vice President...Operation at Xencor, Inc.; and Vice President...senior positions at Onyx ...

Ardea Biosciences Reports Positive Results from Combination of RDEA594 and Febuxostat.
PR Newswire; 12/1/2009; 1488 words; ...Ardea Biosciences, Inc. today announced...Uloric[R], Takeda Pharmaceutical Company Limited...Ardea Biosciences, Inc. Ardea Biosciences, Inc., of San Diego...Bayer HealthCare, Onyx Pharmaceuticals) in advanced cancer...

NewCo News: Scripps Spinout Xcovery Sees Room for Kinase Improvement.
BIOWORLD Today; 12/1/2009; 1117 words; ...about a third of all pharmaceutical discovery efforts...and CEO of Xcovery Inc., would argue the...Nexavar (sorafenib, Onyx Pharmaceuticals Inc. and Bayer AG), Sutent (sunitinib, Pfizer Inc.), Tarceva (erlotinib...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.